Literature DB >> 19875163

Adjustment of dosing of antimicrobial agents for bodyweight in adults.

Matthew E Falagas1, Drosos E Karageorgopoulos.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19875163     DOI： 10.1016/S0140-6736(09)60743-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  29 in total

Review 1.  Management of antimicrobial use in the intensive care unit.

Authors:  Francisco Álvarez-Lerma; Santiago Grau
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

2.  Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

Authors:  Simone van Kralingen; Margot Taks; Jeroen Diepstraten; Ewoudt M van de Garde; Eric P van Dongen; Marinus J Wiezer; Bert van Ramshorst; Bart Vlaminckx; Vera H Deneer; Catherijne A Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2011-04-16       Impact factor: 2.953

3.  Electrochemical Aptamer-Based Sensors for Improved Therapeutic Drug Monitoring and High-Precision, Feedback-Controlled Drug Delivery.

Authors:  Philippe Dauphin-Ducharme; Kyungae Yang; Netzahualcóyotl Arroyo-Currás; Kyle L Ploense; Yameng Zhang; Julian Gerson; Martin Kurnik; Tod E Kippin; Milan N Stojanovic; Kevin W Plaxco
Journal:  ACS Sens       Date:  2019-10-15       Impact factor: 7.711

Review 4.  Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.

Authors:  Hans-Georg Eichler; Eric Abadie; Alasdair Breckenridge; Bruno Flamion; Lars L Gustafsson; Hubert Leufkens; Malcolm Rowland; Christian K Schneider; Brigitte Bloechl-Daum
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

Review 5.  Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere.

Authors:  M E Falagas; N V Cholevas; A M Kapaskelis; E K Vouloumanou; A Michalopoulos; P I Rafailidis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-13       Impact factor: 3.267

6.  Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients.

Authors:  Timothy P Gauthier; William R Wolowich; Arathi Reddy; Ennie Cano; Lilian Abbo; Laura B Smith
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

7.  The art of targeting gut microbiota for tackling human obesity.

Authors:  Marisol Aguirre; Koen Venema
Journal:  Genes Nutr       Date:  2015-05-20       Impact factor: 5.523

Review 8.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

9.  Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients.

Authors:  Pierre Moine; Scott W Mueller; Jonathan A Schoen; Kevin B Rothchild; Douglas N Fish
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  Diverticular disease and the obese patient.

Authors:  Eric K Johnson; Bradley J Champagne
Journal:  Clin Colon Rectal Surg       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.